A citation-based method for searching scientific literature

Véronique M André, Carlos Cepeda, Angela Venegas, Yeranui Gomez, Michael S Levine. J Neurophysiol 2006
Times Cited: 54







List of co-cited articles
1092 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
59


NMDA receptor function in mouse models of Huntington disease.
C Cepeda, M A Ariano, C R Calvert, J Flores-Hernández, S H Chandler, B R Leavitt, M R Hayden, M S Levine. J Neurosci Res 2001
209
55

Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.
Carlos Cepeda, Raymond S Hurst, Christopher R Calvert, Elizabeth Hernández-Echeagaray, Oanh K Nguyen, Emily Jocoy, Lindsey J Christian, Marjorie A Ariano, Michael S Levine. J Neurosci 2003
256
53

The corticostriatal pathway in Huntington's disease.
Carlos Cepeda, Nanping Wu, Véronique M André, Damian M Cummings, Michael S Levine. Prog Neurobiol 2007
232
53

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
51

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.
G J Klapstein, R S Fisher, H Zanjani, C Cepeda, E S Jokel, M F Chesselet, M S Levine. J Neurophysiol 2001
248
48

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
48

Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.
G A Laforet, E Sapp, K Chase, C McIntyre, F M Boyce, M Campbell, B A Cadigan, L Warzecki, D A Tagle, P H Reddy,[...]. J Neurosci 2001
205
42

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.
J G Hodgson, N Agopyan, C A Gutekunst, B R Leavitt, F LePiane, R Singaraja, D J Smith, N Bissada, K McCutcheon, J Nasir,[...]. Neuron 1999
637
42

Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease.
Amaal J Starling, Véronique M André, Carlos Cepeda, Marianne de Lima, Scott H Chandler, Michael S Levine. J Neurosci Res 2005
70
42

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
591
42

Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease.
M S Levine, G J Klapstein, A Koppel, E Gruen, C Cepeda, M E Vargas, E S Jokel, E M Carpenter, H Zanjani, R S Hurst,[...]. J Neurosci Res 1999
258
38

Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.
Damian M Cummings, Véronique M André, Besim O Uzgil, Steven M Gee, Yvette E Fisher, Carlos Cepeda, Michael S Levine. J Neurosci 2009
122
38

Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.
Melinda M Zeron, Oskar Hansson, Nansheng Chen, Cheryl L Wellington, Blair R Leavitt, Patrik Brundin, Michael R Hayden, Lynn A Raymond. Neuron 2002
453
35

Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease.
Austen J Milnerwood, Damian M Cummings, Glenn M Dallérac, Jacki Y Brown, Sarat C Vatsavayai, Mark C Hirst, Payam Rezaie, Kerry P S J Murphy. Hum Mol Genet 2006
112
33

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Michelle Gray, Dyna I Shirasaki, Carlos Cepeda, Véronique M André, Brian Wilburn, Xiao-Hong Lu, Jifang Tao, Irene Yamazaki, Shi-Hua Li, Yi E Sun,[...]. J Neurosci 2008
448
33

Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice.
Austen J Milnerwood, Clare M Gladding, Mahmoud A Pouladi, Alexandra M Kaufman, Rochelle M Hines, Jamie D Boyd, Rebecca W Y Ko, Oana C Vasuta, Rona K Graham, Michael R Hayden,[...]. Neuron 2010
348
33

Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.
Prasad R Joshi, Nan-Ping Wu, Véronique M André, Damian M Cummings, Carlos Cepeda, John A Joyce, Jeffrey B Carroll, Blair R Leavitt, Michael R Hayden, Michael S Levine,[...]. J Neurosci 2009
129
33

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.
R Luthi-Carter, A Strand, N L Peters, S M Solano, Z R Hollingsworth, A S Menon, A S Frey, B S Spektor, E B Penney, G Schilling,[...]. Hum Mol Genet 2000
568
31



Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation.
K P Murphy, R J Carter, L A Lione, L Mangiarini, A Mahal, G P Bates, S B Dunnett, A J Morton. J Neurosci 2000
287
29

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
29

Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.
J H Cha, C M Kosinski, J A Kerner, S A Alsdorf, L Mangiarini, S W Davies, J B Penney, G P Bates, A B Young. Proc Natl Acad Sci U S A 1998
414
29

Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect.
Michael S Levine, Carlos Cepeda, Miriam A Hickey, Sheila M Fleming, Marie-Françoise Chesselet. Trends Neurosci 2004
127
29

Differential loss of striatal projection neurons in Huntington disease.
A Reiner, R L Albin, K D Anderson, C J D'Amato, J B Penney, A B Young. Proc Natl Acad Sci U S A 1988
744
29

Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF.
Carlos Cepeda, Amaal J Starling, Nanping Wu, Oanh K Nguyen, Besim Uzgil, Takahiro Soda, Veronique M André, Marjorie A Ariano, Michael S Levine. J Neurosci Res 2004
102
29

Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice.
Xiaofeng Gu, Chenjian Li, Weizheng Wei, Victor Lo, Shiaoching Gong, Shi-Hua Li, Takuji Iwasato, Shigeyoshi Itohara, Xiao-Jiang Li, Istvan Mody,[...]. Neuron 2005
174
29

Striatal potassium channel dysfunction in Huntington's disease transgenic mice.
Marjorie A Ariano, Carlos Cepeda, Christopher R Calvert, Jorge Flores-Hernández, Elizabeth Hernández-Echeagaray, Gloria J Klapstein, Scott H Chandler, Neil Aronin, Marian DiFiglia, Michael S Levine. J Neurophysiol 2005
82
27

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
S W Davies, M Turmaine, B A Cozens, M DiFiglia, A H Sharp, C A Ross, E Scherzinger, E E Wanker, L Mangiarini, G P Bates. Cell 1997
27

Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease.
Damian M Cummings, Austen J Milnerwood, Glenn M Dallérac, Verina Waights, Jacki Y Brown, Sarat C Vatsavayai, Mark C Hirst, Kerry P S J Murphy. Hum Mol Genet 2006
88
27

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
C Zuccato, A Ciammola, D Rigamonti, B R Leavitt, D Goffredo, L Conti, M E MacDonald, R M Friedlander, V Silani, M R Hayden,[...]. Science 2001
942
27

Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease.
Jeremy M Van Raamsdonk, Jacqueline Pearson, Elizabeth J Slow, Sazzad M Hossain, Blair R Leavitt, Michael R Hayden. J Neurosci 2005
232
25

Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Liliana B Menalled, Jessica D Sison, Ioannis Dragatsis, Scott Zeitlin, Marie-Françoise Chesselet. J Comp Neurol 2003
340
24


Regional cortical thinning in preclinical Huntington disease and its relationship to cognition.
H D Rosas, N D Hevelone, A K Zaleta, D N Greve, D H Salat, B Fischl. Neurology 2005
234
24

Altered information processing in the prefrontal cortex of Huntington's disease mouse models.
Adam G Walker, Benjamin R Miller, Jenna N Fritsch, Scott J Barton, George V Rebec. J Neurosci 2008
67
24

Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease.
Michael A Johnson, Vignesh Rajan, Charles E Miller, R Mark Wightman. J Neurochem 2006
95
22

Impaired glutamate uptake in the R6 Huntington's disease transgenic mice.
J C Liévens, B Woodman, A Mahal, O Spasic-Boscovic, D Samuel, L Kerkerian-Le Goff, G P Bates. Neurobiol Dis 2001
218
22

Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease.
J C Hedreen, C E Peyser, S E Folstein, C A Ross. Neurosci Lett 1991
223
22


Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease.
Jacqueline Shehadeh, Herman B Fernandes, Melinda M Zeron Mullins, Rona K Graham, Blair R Leavitt, Michael R Hayden, Lynn A Raymond. Neurobiol Dis 2006
91
22

Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin.
Shu-ichi Okamoto, Mahmoud A Pouladi, Maria Talantova, Dongdong Yao, Peng Xia, Dagmar E Ehrnhoefer, Rameez Zaidi, Arjay Clemente, Marcus Kaul, Rona K Graham,[...]. Nat Med 2009
314
22

Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease.
Benjamin R Miller, Adam G Walker, Anand S Shah, Scott J Barton, George V Rebec. J Neurophysiol 2008
87
22

Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease.
M Turmaine, A Raza, A Mahal, L Mangiarini, G P Bates, S W Davies. Proc Natl Acad Sci U S A 2000
350
20

Striatal neurochemical changes in transgenic models of Huntington's disease.
Marjorie A Ariano, Neil Aronin, Marian Difiglia, Danilo A Tagle, David R Sibley, Blair R Leavitt, Michael R Hayden, Michael S Levine. J Neurosci Res 2002
72
20

Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.
R J Carter, L A Lione, T Humby, L Mangiarini, A Mahal, G P Bates, S B Dunnett, A J Morton. J Neurosci 1999
700
20


Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.
Laurent R Gauthier, Bénédicte C Charrin, Maria Borrell-Pagès, Jim P Dompierre, Hélène Rangone, Fabrice P Cordelières, Jan De Mey, Marcy E MacDonald, Volkmar Lessmann, Sandrine Humbert,[...]. Cell 2004
798
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.